These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up. Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P; J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947 [TBL] [Abstract][Full Text] [Related]
13. Clinical Features and Gaps in the Management of Probable Familial Hypercholesterolemia and Cardiovascular Disease. Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C Circ J; 2017 Dec; 82(1):218-223. PubMed ID: 28701632 [TBL] [Abstract][Full Text] [Related]
15. [Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment]. Češka R; Štulc T; Votavová L; Schwarzová L; Vaclová M; Freiberger T Vnitr Lek; 2016; 62(11):887-894. PubMed ID: 28128575 [TBL] [Abstract][Full Text] [Related]
16. Familial hypercholesterolaemia in pregnancy: Australian case series and review. Nangrahary M; Graham DF; Pang J; Barnett W; Watts GF Aust N Z J Obstet Gynaecol; 2023 Jun; 63(3):402-408. PubMed ID: 36883608 [TBL] [Abstract][Full Text] [Related]
17. New data on familial hypercholesterolaemia and acute coronary syndromes: The promise of PCSK9 monoclonal antibodies in the light of recent clinical trials. Ellis KL; Pang J; Schultz CJ; Watts GF Eur J Prev Cardiol; 2017 Jul; 24(11):1200-1205. PubMed ID: 28482694 [TBL] [Abstract][Full Text] [Related]
18. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia. Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356 [TBL] [Abstract][Full Text] [Related]
19. Marked aortic valve stenosis progression after receiving long-term aggressive cholesterol-lowering therapy using low-density lipoprotein apheresis in a patient with familial hypercholesterolemia. Tsuchida M; Kawashiri MA; Tada H; Takata M; Nohara A; Ino H; Inazu A; Kobayashi J; Koizumi J; Mabuchi H; Yamagishi M Circ J; 2009 May; 73(5):963-6. PubMed ID: 19088396 [TBL] [Abstract][Full Text] [Related]